Business

On March 1, Judge John Koeltl of the US District Court for the Southern District of New York issued a partial summary judgment in Mylan's patent infringement suit against Sunovion Pharmaceuticals, invalidating 5 of the 7 patents regarding Brovana arformoterol tartrate inhalation solution cited in the suit filed by Mylan's subsidiary Dey against Sunovion (formerly … [Read more...] about Mylan to appeal invalidation of inhalation solution patents

A company called GSC Products has launched what it says is "the world's first caffeine nasal spray" in the US. GSC says that the product, called Turbo Snort, was introduced on the Internet in January and is now sold in more than 500 independent convenience stores. GSC CEO Wayne Perry said, "By delivering caffeine through the nose, it bypasses the systemic processes … [Read more...] about Caffeine nasal spray launched in US

Aradigm has announced that the United States Patent and Trademark Office has issued an additional patent covering several formulations of ciprofloxacin, including the company's lead product, Pulmaquin dual release ciprofloxacin for inhalation. The patent (US Patent No. 8,119,156) will provide exclusivity for Pulmaquin until October 22, 2028. The company, which … [Read more...] about US Patent Office issues new patent for Aradigm’s Pulmaquin

Irish nebulizer manufacturer Aerogen has received authorization from the Chinese State Food and Drug Administration (SFDA) to market its Aeroneb Pro and Aeroneb Go vibrating mesh nebulizers in China. The company expects to begin selling the products in the country by March 2012, with distributed handled by Gaelmed. Aerogen currently markets products in 65 countries. … [Read more...] about Aerogen authorized to market nebulizers in China

Alexza Pharmaceuticals, which is developing a number of inhaled drugs using its proprietary Staccato inhaler, will offer 44,000,000 shares of common stock and 44,000,000 warrants to purchase common stock at $0.50 per share for a total offer of $22 million. One warrant to purchase a common share will be sold with each common share. According to the company, the money … [Read more...] about Alexza offers common stock and warrants

Critical Pharmaceuticals and the University of Nottingham have announced a new partnership for development of a "nano-enabled" intranasal formulation of teriparatide for the treatment of osteoporosis. Funding for the £545,000 collaboration is coming from the Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC). “We are … [Read more...] about Critical Pharmaceuticals and U. of Nottingham team on osteoporosis nasal spray

US pharmaceutical company Acorda Therapeutics President and CEO Ron Cohen has announced that the company is "excited" about an agreement with Neuronex, Inc. that will allow Acorda to acquire the company and its diazepam nasal spray program. Acorda has made an upfront payment of $2 million to acquire Neuronex, a North Carolina-based pharmaceutical company, plus … [Read more...] about Acorda acquires Neuronex, diazepam nasal spray program

A jury has awarded $18 million to Sunovion Pharmaceuticals after finding that Mylan willfully infringed on patents for Xopenex levalbuterol hydrochloride inhalation solution when its subsidiary Dey marketed generic versions of the product. The trial took place in the US District Court for the District of Delaware. The patents involved are US patents numbers … [Read more...] about Mylan says it will challenge verdict in Sunovion Xopenex patent infringement suit

A new report from IbisWorld foresees a positive outlook for nebulizer sales after estimated annualized growth rate of 6.2% from 2007 to 2012. The report suggests that an aging population and increasing diagnoses of respiratory illnesses, plus an improving economy will help manufacturers to overcome "some market saturation and new federal regulations." Total revenue … [Read more...] about Report estimates 6.2% increase in nebulizer sales over 5-year period